Late-onset neutropenia following rituximab therapy in rheumatic diseases: Association with B lymphocyte depletion and infections-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Late-onset neutropenia following rituximab therapy in rheumatic diseases: Association with B lymphocyte depletion and infections

Published:2011-08 Issue:8 Volume:63 Page:2209-2214
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Tesfa Daniel,Ajeganova Sofia,Hägglund Hans,Sander Birgitta,Fadeel Bengt,Hafström Ingiäld,Palmblad Jan

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference11 articles.

1. Late-onset neutropenia after rituximab treatment: case series and comprehensive review of the literature;Wolach;Medicine (Baltimore),2010

2. Late-onset neutropenia following rituximab treatment in patients with autoimmune diseases;Rios-Fernandez;Br J Dermatol,2007

3. Rituximab-related late-onset neutropenia in a patient with severe rheumatoid arthritis;Marotte;Ann Rheum Dis,2008

4. A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis;Jones;Arthritis Rheum,2009

5. Rituximab as maintenance therapy for anti-neutrophil cytoplasmic antibody-associated vasculitis;Rhee;Clin J Am Soc Nephrol,2010

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody-Based Biotherapeutics in Cancer;Pharmaceutical Biotechnology;2024

2. Non-late-onset neutropaenia following treatment of multiple sclerosis with ocrelizumab;Neurología (English Edition);2023-09

3. Hypogammaglobulinemia, late-onset neutropenia, and infections following rituximab;Annals of Allergy, Asthma & Immunology;2023-06

4. Longitudinal monitoring of circulating immune cell phenotypes in anti-neutrophil cytoplasmic antibody-associated vasculitis;Autoimmunity Reviews;2023-03

5. Combination of granulomatosis with polyangiitis with COVID-19: difficulties in differential diagnosis and treatment;South Russian Journal of Therapeutic Practice;2022-12-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3